Clorox Co /De/ (CLX) Stock Price & Analysis
Clorox Co /De/ (CLX) rose 3.49% to USD 98.48 as of June 9, 2026 at 22:33 UTC, according to Nexqual real-time market data.
CLX last closed at USD 95.16; the session ranged USD 95.75–98.64 on volume of 2,622,392 shares. Market capitalization is $11.91B, with a 52-week range of USD 84.7–132.03 (NYQ). Source: Nexqual, June 9, 2026 at 22:33 UTC.
Key Statistics (as of June 9, 2026 at 22:33 UTC)
| Price | USD 98.48 |
|---|---|
| Change | ▲ 3.49% (up) |
| Previous Close | USD 95.16 |
| Open | USD 95.75 |
| Day Range | USD 95.75 – 98.64 |
| 52-Week Range | USD 84.7 – 132.03 |
| Volume | 2,622,392 shares |
| Market Cap | $11.91B |
| Exchange | NYQ |
Technical Analysis (CLX)
Nexqual's technical model rates CLX "BUY" based on 4 bullish and 2 bearish signals across 124 daily candles, as of June 9, 2026 at 22:33 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 59.49 (neutral) |
| vs SMA50 | Above (USD 96.3) |
| MACD | -0.47 (negative) |
Analyst Ratings (CLX)
Wall Street analysts rate CLX "Hold" based on 17 analysts, with a mean price target of USD 105.29 (range USD 83–163), per Nexqual as of June 9, 2026 at 22:33 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 17 |
| Mean Target | USD 105.29 |
| High Target | USD 163 |
| Low Target | USD 83 |
| Buy / Hold / Sell | 2 / 13 / 4 |
Earnings (CLX)
| Next Earnings Date | 2026-07-30 |
|---|---|
| EPS Estimate | USD 1.66 |
| Revenue Estimate | $1.91B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 1.64 vs est 1.54 ▲ beat |
| 2025-12-31 | USD 1.39 vs est 1.43 ▼ miss |
| 2025-09-30 | USD 0.85 vs est 0.78 ▲ beat |
| 2025-06-30 | USD 2.87 vs est 2.21 ▲ beat |
Source: Nexqual, June 9, 2026 at 22:33 UTC.
Financials & Fundamentals (CLX)
| Total Revenue | $6.76B |
|---|---|
| Revenue Growth (YoY) | +0.10% |
| Gross Margin | +43.85% |
| Operating Margin | +17.01% |
| Profit Margin | +11.18% |
| ROE | +546.10% |
| Debt / Equity | 4,876.09 |
| Current Ratio | 0.84 |
| Total Cash | $1.19B |
| Total Debt | $4.49B |
| Free Cash Flow | $62.75M |
Source: Nexqual, June 9, 2026 at 22:33 UTC.
Financial Health Score (CLX)
Nexqual rates Clorox Co /De/'s overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 22:33 UTC.
| Growth | Mixed — Revenue +0.2% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 44%, operating 17% |
| Balance Sheet | Critical — $1.19B cash vs $4.49B debt |
| Cash Flow | Mixed — FCF $63M, slim 0.9% margin |
| Efficiency | Strong — ROE 546%, ROA 11.0% |
Ownership (CLX)
| Insider Ownership | +0.61% |
|---|---|
| Institutional Ownership | +86.39% |
| Shares Outstanding | 120.92M |
| Float | 120.51M |
| Short % of Float | +8.94% |
Source: Nexqual, June 9, 2026 at 22:33 UTC.
Leadership (CLX)
Clorox Co /De/ is led by Linda J. Rendle (age 47), CEO & Chairman, per Nexqual as of June 9, 2026 at 22:33 UTC.
| CEO & Chairman | Linda J. Rendle (age 47) |
|---|---|
| Executive VP & CFO | Luc Bellet (age 46) |
| Executive VP and Group President of Health & Hygiene | Chris T. Hyder (age 49) |
| Executive VP and Group President of Care & Connection | Nina Barton (age 51) |
| Vice President of Investor Relations | Lisah Burhan |
Major Backers & Investors (CLX)
Notable institutional backers of Clorox Co /De/ include Invesco, Van Eck Associates Corporation, VanEck ETF Trust-VanEck Morningstar Wide Moat ETF, according to Nexqual as of June 9, 2026 at 22:33 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Invesco | 5.26% |
| Van Eck Associates Corporation | 2.66% |
| VanEck ETF Trust-VanEck Morningstar Wide Moat ETF | 2.37% |
| Morgan Stanley | 2.25% |
| ProShares Trust-ProShares S&P 500 Dividend Aristocrats ETF | 1.36% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 20.76% |
| BlackRock | 9.7% |
| State Street | 8.03% |
| Geode Capital | 2.67% |
| Northern Trust | 1.32% |
Source: Nexqual, June 9, 2026 at 22:33 UTC.
From Clorox Co /De/'s Latest SEC 10-K Filing (filed 2025-08-08)
Key Strengths & Strategy (as disclosed to the SEC)
- The Company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro ™ and Clorox Healthcare ® brand names.
- The Company also launched numerous innovations and new products in fiscal year 2025, including seven new Hidden Valley Ranch flavors, new scent options for Scentiva Bleach and Poett Multi-Purpose Cleaner, Burt's Bees Tinted Boosted Lip Balm and Rescue Lip Relief, Ever Clean Senior Cat Litter as well as Fresh Step Heavy Duty Litter, Kingsford Beercoal charcoal briquettes and the Brita Plus System.
- The ERP system implementation, expected to be completed in the U.S. during fiscal year 2026, has required and will continue to require investment of personnel and financial resources to support post-implementation efforts and system functionality.
Partnerships
- In February 2025, the Company announced that the Venture Agreement with The Procter & Gamble Company (P&G) for the Company's Glad bags and wraps business will wind down by January 31, 2026.
- In connection with its strategy, the Company expects to continue to seek acquisition, joint venture and investment opportunities.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KMB | Kimberly-Clark Corporation | USD 100.52 | ▲ 1.49% |
| CL | Colgate-Palmolive Company | USD 87.8 | ▼ 0.88% |
| GIS | General Mills, Inc. | USD 33.72 | ▲ 1.72% |
| MKC | McCormick & Company, Incorporat | USD 48.63 | ▲ 2.94% |
| HRL | Hormel Foods Corporation | USD 23.98 | ▲ 1.52% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 22:33 UTC. This page is informational and not investment advice.